À propos
Dr Mohammed Abdul-latif is a Consultant Clinical Oncologist with a specialist interest in urological and gynaecological malignancies, as well as complex brachytherapy. He serves as the Clinical Lead for the brachytherapy department at Mount Vernon Cancer Centre, where he delivers advanced brachytherapy treatments for a range of cancers.
He graduated in the top decile of his cohort from Imperial College School of Medicine in 2013. Following graduation, he undertook postgraduate training in North London hospitals, rotating through general medicine and clinical oncology. He has completed a Postgraduate Diploma (PGDip) in Oncology and a Doctorate of Medicine (MD) at the University of Manchester under the supervision of Professor Peter Hoskin. His doctoral research focused on the role of functional MRI in cervical cancer. He continues to publish academic work and regularly presents at international conferences, including ESTRO.
Dr Abdul-latif is trained in the delivery of complex brachytherapy for gynaecological, urological, oesophageal, and rectal cancers, including contact radiotherapy. He also performs interstitial treatments for rarer cancers such as those of the skin, breast, and soft tissues. He routinely implants hydrogel spacers (SpaceOAR) as part of prostate cancer treatment protocols.
He has a keen interest in the delivery of systemic therapies, managing patients with requiring chemotherapy, targeted therapies and immunotherapy in a range of settings.
He was awarded the Royal College of Radiologists' Kay-Durrant Fellowship, which enabled him to travel to France and Italy to gain additional experience in breast, rectal, and head and neck brachytherapy.
He graduated in the top decile of his cohort from Imperial College School of Medicine in 2013. Following graduation, he undertook postgraduate training in North London hospitals, rotating through general medicine and clinical oncology. He has completed a Postgraduate Diploma (PGDip) in Oncology and a Doctorate of Medicine (MD) at the University of Manchester under the supervision of Professor Peter Hoskin. His doctoral research focused on the role of functional MRI in cervical cancer. He continues to publish academic work and regularly presents at international conferences, including ESTRO.
Dr Abdul-latif is trained in the delivery of complex brachytherapy for gynaecological, urological, oesophageal, and rectal cancers, including contact radiotherapy. He also performs interstitial treatments for rarer cancers such as those of the skin, breast, and soft tissues. He routinely implants hydrogel spacers (SpaceOAR) as part of prostate cancer treatment protocols.
He has a keen interest in the delivery of systemic therapies, managing patients with requiring chemotherapy, targeted therapies and immunotherapy in a range of settings.
He was awarded the Royal College of Radiologists' Kay-Durrant Fellowship, which enabled him to travel to France and Italy to gain additional experience in breast, rectal, and head and neck brachytherapy.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Mohammed Abdul-latif
Formation et études
-
2002–2008 MD · Medicine and Surgery
-
2008–2012 Residency · Oncologie
-
2012–2013 Fellowship · Subspecialty training
Carrière et postes
-
2012-09–2013-08 Junior consultant
Licences et assurance
Licences médicales
GB — Organización Médica Colegial de España (OMC)
Certifications du conseil
European Board of Oncologie
Assurance responsabilité professionnelle :
HDI Global · 5,000,000 EUR couverture · No claims on file
Procédures réalisées
| Procédure | Code | Total à vie |
|---|---|---|
| GP consultation | 99213 | 1,413 |
| Annual physical exam | 99395 | 435 |
| Vaccination administration | 90471 | 2,499 |
| Minor procedure (skin) | 17110 | 2,868 |
Services et tarifs
| Service | Durée | Modalité | Prix |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 120 min | in_clinic | 810.00 EUR |
| Minor procedure (skin) | 30 min | in_clinic | 540.00 EUR |
Cabinet, équipe & en pratique
Vidéos
Recherche et publications
indice h : 19 · i10 : 7
-
European registry analysis of Oncologie outcomes
DOI: 10.5319/euroclin.2025.0 · PMID: 35622372 · cité par 85
-
Outcomes of Oncologie in adults — a multi-centre cohort
DOI: 10.5304/euroclin.2024.1 · PMID: 34197352 · cité par 151
Conférences invitées
- Practical updates in Oncologie European Annual Congress (Oncologie) · Vienna · 2024 · invited
- Single-centre experience in Oncologie National Society Meeting · Northwood · 2023 · oral abstract
Récompenses et adhésions
Récompenses
- 🏆 Top-rated Oncologie — Northwood · EuroClinics Patient Choice · 2025 · regional
- 🏆 Excellence in Patient Care · National Society · 2024 · national
Adhésions à des sociétés
- WONCA Europe — Family Doctors — Member · Depuis 2013
- national college of family doctors — Member · Depuis 2013
- European Union of Medical Specialists (UEMS) — Member · Depuis 2013
Articles de ce médecin
- Patient education Patient guide to Oncologie
- Awareness When should you see a oncologie?
Pour les patients internationaux
- Coordinateur
- Patient liaison · mohammed.abdul.latif@euroclinics.example
- Assurances internationales acceptées
- Allianz Worldwide · AXA Global · BUPA Global · Cigna Global
Emplacement
1 baliseAvis des patients
1 avis vérifiés5.00
★★★★★
1 avis
- Bedside Manner
- 5.0
- Knowledge
- 5.0
- Wait Time
- 4.8
- Staff Friendliness
- 5.0
- Ease Of Appointment
- 4.9
- Value For Money
- 4.9
- Would Recommend Pct
- 99.0
Partagez votre expérience — aidez d'autres patients à trouver le bon médecin. Rédiger un avis →
Avis récents
-
★★★★★ ✓ Vérifié Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Vérifié Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Vérifié Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.